OVERVIEW
The global market size of biochips is projected to reach USD 17.88 billion by 2025, rising over the forecast period at a CAGR of 11.72%. Increasing the prevalence of cancer, immunological disorders, and viral infections fuels the growth of the global market for biochips.
TABLE OF CONTENT
1 Global Biochips Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Biochips Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Biochips Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Biochips Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Biochips Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Biochips Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Biochips Market – By Technology (Market Size – & million/billion)
8.1 Microarrays
8.2 Microfluidics
9 Global Biochips Market – By End-User
9.1 Biotechnology and Pharmaceutical Companies
9.2 Hospitals and Diagnostics Centers
9.3 Academic & Research Institutes
9.4 Others
10 Global Biochips Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Biochips Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Biochips Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Abbott Laboratories
12.3 GE Healthcare
12.4 Agilent Technologies, Inc.
12.5 Perkinelmer, Inc.
12.6 Illumina, Inc.
12.7 Cepheid Inc.
12.8 Thermo Fisher Scientific, Inc.
12.9 Roche Diagnostics
12.10 Bio-Rad Laboratories Inc.
12.11 Fluidigm Corporation
12.12 Company 11 & more
13 Global Biochips Market – Appendix
13.1 Sources
13.2 Abbreviations